Key result
Transarterial coronary ethanol ablation guided by preprocedural imaging significantly reduced VT burden from 15.8 to 0.97 therapies/month (P=0.02) in patients with refractory septal VT.
Why the study?
Radiofrequency ablation of ventricular tachycardia due to intramural foci has a high recurrence rate, making alternative strategies such as transarterial coronary ethanol ablation guided by preprocedural imaging needed.
Does preprocedural imaging-guided transarterial coronary ethanol ablation reduce VT burden in patients with refractory septal ventricular tachycardia?
Case Report (n=3)
Does preprocedural imaging-guided transarterial coronary ethanol ablation reduce VT burden in patients with refractory septal ventricular tachycardia?
Preprocedural imaging-guided transarterial coronary ethanol ablation is a feasible and effective alternative for reducing VT burden in patients with intramural septal VT refractory to radiofrequency ablation.
Answers are grounded in this paper and cite their sources.
May support ethanol ablation in refractory septal VT; hypothesis-generating and requires prospective trials before practice change.
BACKGROUND: Radiofrequency ablation (RF) of ventricular tachycardia (VT) due to intramural foci has a high recurrence rate. Several techniques, such as bipolar ablation, irrigated needle ablation catheter, and retrograde coronary venous ethanol ablation have been suggested. Transarterial coronary ethanol ablation (TCEA) can also be effective. We present a case series of TCEA guided with preprocedural imaging to correlated coronary arteries and the intramural substrate. METHODS AND RESULTS: We present three consecutive patients with previous RF of septal VT (100% male; age, 72.6 ± 11.01 years; two patients with hypertrophic cardiomyopathy, one with mechanical aortic valve prosthesis) that underwent TCEA. Cardiac magnetic resonance was performed in two patients and cardiac CT in all patients. Correlation of septal arteries with intramural substrate was analyzed before the procedure so TCEA was attempted according to this analysis. After last TCEA (6.3 ± 2.08 months) the VT burden was reduced in all patients (sum of all implantable cardioverter-defibrillator therapies [antitachycardia pacing and shock] before and after TCEA, 15.8 ± 3.73 vs 0.97 ± 0.63 therapies/month; P = 0.02). No complications occurred during TCEA. CONCLUSIONS: TCEA completely guided with previous magnetic resonance imaging and computed tomography scan to select the coronary artery in relation to the substrate seems to be feasible as an alternative strategy in cases of intramural VT refractory to RF ablation.
No takes yet. Share an insight, caveat, or question.
Roca‐Luque et al. (2018) conducted a case report in Refractory septal ventricular tachycardia (n=3). Transarterial coronary ethanol ablation (TCEA) guided with preprocedural imaging vs. Pre-procedure baseline was evaluated on Ventricular tachycardia burden (sum of all implantable cardioverter-defibrillator therapies per month) (p=0.02). Transarterial coronary ethanol ablation guided by preprocedural imaging significantly reduced VT burden from 15.8 to 0.97 therapies/month (P=0.02) in patients with refractory septal VT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: